Literature DB >> 3304705

Nitrate tolerance: the lack of effect of N-acetylcysteine.

J O Parker, B Farrell, K A Lahey, B F Rose.   

Abstract

The hemodynamic and antianginal effects of 30 mg of isosorbide dinitrate (ISDN) were assessed in 12 patients with chronic stable angina after initial dosing and after 7 to 10 days of therapy four times daily. During early therapy, ISDN produced significant hemodynamic and antianginal effects that persisted over a 3 hr observation period. During sustained therapy there was attenuation of the hemodynamic effects at rest, and treadmill exercise time to the onset of angina and to the development of moderate angina was increased 1 hr after dosing; no effect was apparent at 3 hr. During this state of nitrate tolerance, patients were treated with an infusion of normal saline or 100 mg/kg N-acetylcysteine and exercise testing was repeated. N-Acetylcysteine did not change the hemodynamic findings at rest or during exercise and there was no improvement in exercise tolerance. It is apparent that the short-term administration of reduced sulfhydryl groups does not reverse tolerance to the hemodynamic and antianginal effects of isosorbide dinitrate in an exercise test model.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3304705     DOI: 10.1161/01.cir.76.3.572

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  16 in total

Review 1.  Avoiding nitrate tolerance.

Authors:  J C Cowan
Journal:  Br J Clin Pharmacol       Date:  1992-08       Impact factor: 4.335

Review 2.  An update on nitrate tolerance: can it be avoided?

Authors:  S R Maxwell; M J Kendall
Journal:  Postgrad Med J       Date:  1992-11       Impact factor: 2.401

Review 3.  Update on nitrate tolerance.

Authors:  J O Parker
Journal:  Br J Clin Pharmacol       Date:  1992       Impact factor: 4.335

Review 4.  Nitrates: why and how should they be used today? Current status of the clinical usefulness of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate.

Authors:  S Silber
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 5.  Nitrate tolerance. A problem during continuous nitrate administration.

Authors:  J O Parker
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 6.  The Role of Nitroglycerin and Other Nitrogen Oxides in Cardiovascular Therapeutics.

Authors:  Sanjay Divakaran; Joseph Loscalzo
Journal:  J Am Coll Cardiol       Date:  2017-11-07       Impact factor: 24.094

7.  N-acetylcysteine fails to attenuate haemodynamic tolerance to glyceryl trinitrate in healthy volunteers.

Authors:  J C Hogan; M J Lewis; A H Henderson
Journal:  Br J Clin Pharmacol       Date:  1989-10       Impact factor: 4.335

8.  Release of nitric oxide from glyceryl trinitrate by captopril but not enalaprilat: in vitro and in vivo studies.

Authors:  D Salvemini; A Pistelli; V Mollace
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

9.  Smooth muscle cell expression of type I cyclic GMP-dependent protein kinase is suppressed by continuous exposure to nitrovasodilators, theophylline, cyclic GMP, and cyclic AMP.

Authors:  G A Soff; T L Cornwell; D L Cundiff; S Gately; T M Lincoln
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

Review 10.  Mechanisms of nitrate tolerance.

Authors:  H L Fung; J A Bauer
Journal:  Cardiovasc Drugs Ther       Date:  1994-06       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.